CID 1131

3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]thiazolium

Structural Information

Molecular Formula
C12H18N4O4PS
SMILES
CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)O
InChI
InChI=1S/C12H17N4O4PS/c1-8-11(3-4-20-21(17,18)19)22-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H3-,13,14,15,17,18,19)/p+1
InChIKey
HZSAJDVWZRBGIF-UHFFFAOYSA-O
Compound name
2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl dihydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
7
Annotation Hits

243
References

2068
Patents

345.07864 Da
Monoisotopic Mass

-0.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 346.08592 172.6
[M+Na]+ 368.06786 180.2
[M-H]- 344.07136 172.8
[M+NH4]+ 363.11246 182.9
[M+K]+ 384.04180 170.7
[M+H-H2O]+ 328.07590 165.1
[M+HCOO]- 390.07684 191.2
[M+CH3COO]- 404.09249 199.7
[M+Na-2H]- 366.05331 173.7
[M]+ 345.07809 174.6
[M]- 345.07919 174.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe